Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 459

Sema4 sequences $121m series C

Sema4, spun out of Icahn School of Medicine, has achieved a valuation of more than $1bn following a $121m series C round.

Jul 30, 2020

Sema4 sequences $121m series C

Mount Sinai Health System spinoff Sema4 has achieved a valuation of more than $1bn following a $121m series C round that featured all existing external shareholders.

Jul 30, 2020

Line Man picks up $110m

Line’s on-demand delivery service has attracted $110m from BRV Capital as it merged with restaurant listings website Wongnai Media.

Jul 30, 2020

Humana has $100m for Heal

Heal has entered into a strategic partnership with Humana that includes a $100m investment from the corporate and will support an expansion into additional US cities.

Jul 30, 2020

Remitly receives $85m led by PayU

PayU returned to lead an $85m funding round for Remitly as demand for its cross-border money transfer service continues to grow amid the pandemic.

Jul 30, 2020

Eargo listens to Nan Fung again for $71m

Nan Fung Life Sciences formed part of a consortium of new and existing backers that injected $71m into hearing aid manufacturer Eargo.

Jul 30, 2020

Guoquan Shihui dishes up $60m series C

Sanquan Food-backed convenience store operator Guoquan Shihui has raised $60m in series C funding to bring its total capital to more than $123m.

Jul 30, 2020

Density quantifies $51m series C

Lincoln Property Company has contributed to a $51m series C round for Density, which has created technology to anonymously count the number of people in a space.

Jul 30, 2020

Toppr scales $46m series D heights

AI-powered online education platform Toppr will look to scale its offering following a $46m series D round, though Brand Capital did not return for the latest capital injection.

Jul 30, 2020

J-Pharma takes in $16.3m

Osaka University Venture Capital was among the investors in a series D round for Kyorin University-founded cancer treatment developer J-Pharma.

Jul 30, 2020
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here